DE69417554T2 - Verfahren zur herstellung von aminoalkylguanidinen - Google Patents

Verfahren zur herstellung von aminoalkylguanidinen

Info

Publication number
DE69417554T2
DE69417554T2 DE69417554T DE69417554T DE69417554T2 DE 69417554 T2 DE69417554 T2 DE 69417554T2 DE 69417554 T DE69417554 T DE 69417554T DE 69417554 T DE69417554 T DE 69417554T DE 69417554 T2 DE69417554 T2 DE 69417554T2
Authority
DE
Germany
Prior art keywords
pct
date
sec
jun
protected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69417554T
Other languages
English (en)
Other versions
DE69417554D1 (de
Inventor
Jan-Erik Nystroem
Hans Sjoebom
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
Astra AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra AB filed Critical Astra AB
Publication of DE69417554D1 publication Critical patent/DE69417554D1/de
Application granted granted Critical
Publication of DE69417554T2 publication Critical patent/DE69417554T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C277/00Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C277/08Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups of substituted guanidines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/24Y being a hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DE69417554T 1993-06-03 1994-06-01 Verfahren zur herstellung von aminoalkylguanidinen Expired - Lifetime DE69417554T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE19939301912A SE9301912D0 (sv) 1993-06-03 1993-06-03 Process for the production of aminoalkylguandines
PCT/SE1994/000517 WO1994029269A1 (en) 1993-06-03 1994-06-01 Process for the production of aminoalkylguanidines

Publications (2)

Publication Number Publication Date
DE69417554D1 DE69417554D1 (de) 1999-05-06
DE69417554T2 true DE69417554T2 (de) 1999-09-02

Family

ID=20390162

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69417554T Expired - Lifetime DE69417554T2 (de) 1993-06-03 1994-06-01 Verfahren zur herstellung von aminoalkylguanidinen

Country Status (27)

Country Link
US (1) US5659071A (de)
EP (1) EP0701550B1 (de)
JP (1) JP3662925B2 (de)
CN (1) CN1124956A (de)
AT (1) ATE178316T1 (de)
AU (1) AU674970B2 (de)
BR (1) BR9406713A (de)
CA (1) CA2162920C (de)
CZ (1) CZ320095A3 (de)
DE (1) DE69417554T2 (de)
DK (1) DK0701550T3 (de)
EE (1) EE9400348A (de)
ES (1) ES2131688T3 (de)
FI (1) FI120093B (de)
GR (1) GR3030501T3 (de)
HR (1) HRP940317A2 (de)
HU (1) HUT74293A (de)
IL (1) IL109683A0 (de)
IS (1) IS4165A (de)
LT (1) LT3309B (de)
NO (1) NO305514B1 (de)
NZ (1) NZ267192A (de)
PL (1) PL311760A1 (de)
SE (1) SE9301912D0 (de)
SK (1) SK151895A3 (de)
WO (1) WO1994029269A1 (de)
YU (1) YU33594A (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610308A (en) * 1995-05-18 1997-03-11 Bristol-Myers Squibb Company Process for preparing intermediates for thrombin inhibitors
EP0865445B1 (de) * 1995-12-09 2003-04-02 Akzo Nobel N.V. 3-aminoethyl-n-amidino-2,5-dihydropyrrol derivative mit arginine-mimetischen eigenschaften
AR035216A1 (es) 2000-12-01 2004-05-05 Astrazeneca Ab Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios
US7129233B2 (en) * 2000-12-01 2006-10-31 Astrazeneca Ab Mandelic acid derivatives and their use as thrombin inhibitors
FR2822463B1 (fr) 2001-03-21 2004-07-30 Lipha Derives bicycliques de guanidines et leurs applications en therapeutique
AR034517A1 (es) 2001-06-21 2004-02-25 Astrazeneca Ab Formulacion farmaceutica
SE0201661D0 (sv) 2002-05-31 2002-05-31 Astrazeneca Ab New salts
SE0201659D0 (sv) 2002-05-31 2002-05-31 Astrazeneca Ab Modified release pharmaceutical formulation
US7781424B2 (en) * 2003-05-27 2010-08-24 Astrazeneca Ab Modified release pharmaceutical formulation
US7524354B2 (en) * 2005-07-07 2009-04-28 Research Foundation Of State University Of New York Controlled synthesis of highly monodispersed gold nanoparticles
US9375499B2 (en) * 2006-07-14 2016-06-28 Wisconsin Alumni Research Foundation Adsorptive membranes for trapping viruses
TW200827336A (en) 2006-12-06 2008-07-01 Astrazeneca Ab New crystalline forms
US20090061000A1 (en) * 2007-08-31 2009-03-05 Astrazeneca Ab Pharmaceutical formulation use 030
JP6006634B2 (ja) * 2011-12-28 2016-10-12 東和薬品株式会社 イソウレア化合物を用いるエピナスチンの製造方法
CN106132926B (zh) * 2014-03-28 2019-05-21 株式会社钟化 三苄氧羰基精氨酸的制造方法
WO2020106454A2 (en) * 2018-11-07 2020-05-28 Regents Of The University Of Minnesota Analgesic and anti-addictive compositions for treatment of chronic pain and opioid addiction

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE463576C (de) * 1924-08-06 1928-07-31 Schering Kahlbaum Akt Ges Verfahren zur Darstellung von Aminoguanidinen oder deren Salzen
FR2294699A1 (fr) * 1974-12-19 1976-07-16 Bottu Nouveaux derives du pyrazole et compositions pharmaceutiques les renfermant
HU178398B (en) * 1979-06-12 1982-04-28 Gyogyszerkutato Intezet Process for producing new agmatine derivatives of activity against haemagglutination
US4387049A (en) 1982-02-22 1983-06-07 Smithkline Beckman Corporation Adamantyl containing peptides
DE3222342A1 (de) * 1982-06-14 1983-12-15 Hoechst Ag, 6230 Frankfurt 6-aryl-1,2,4-triazolo (4,3-b) pyridazin-3-carbaminate, ihre herstellung und sie enthaltende arzneimittel
US4914189A (en) * 1987-02-05 1990-04-03 The Adminstrators Of The Tulane Educational Fund Synthetic GHRH analogs
ES2086127T5 (es) * 1991-07-03 1999-11-01 Du Pont Composiciones azeotropicas o semejantes a azeotropos de pentafluoroetano y propano o isobutano.
US5498724A (en) * 1994-06-28 1996-03-12 Aktiebolaget Astra Pyrazoleamidine compounds

Also Published As

Publication number Publication date
AU6940494A (en) 1995-01-03
FI955800A0 (fi) 1995-12-01
DK0701550T3 (da) 1999-10-11
BR9406713A (pt) 1996-03-19
GR3030501T3 (en) 1999-10-29
CA2162920C (en) 2005-08-09
CN1124956A (zh) 1996-06-19
IL109683A0 (en) 1994-08-26
FI955800A (fi) 1995-12-01
HU9503444D0 (en) 1996-01-29
WO1994029269A1 (en) 1994-12-22
LTIP1940A (en) 1994-12-27
NO954835L (no) 1995-11-28
SE9301912D0 (sv) 1993-06-03
IS4165A (is) 1994-12-04
US5659071A (en) 1997-08-19
HUT74293A (en) 1996-11-28
JPH08511016A (ja) 1996-11-19
CZ320095A3 (en) 1996-07-17
AU674970B2 (en) 1997-01-16
SK151895A3 (en) 1996-04-03
FI120093B (fi) 2009-06-30
ES2131688T3 (es) 1999-08-01
NO954835D0 (no) 1995-11-28
NO305514B1 (no) 1999-06-14
EE9400348A (et) 1996-04-15
YU33594A (sh) 1997-05-28
ATE178316T1 (de) 1999-04-15
JP3662925B2 (ja) 2005-06-22
EP0701550A1 (de) 1996-03-20
LT3309B (en) 1995-06-26
CA2162920A1 (en) 1994-12-22
DE69417554D1 (de) 1999-05-06
NZ267192A (en) 1997-03-24
PL311760A1 (en) 1996-03-18
HRP940317A2 (en) 1996-10-31
EP0701550B1 (de) 1999-03-31

Similar Documents

Publication Publication Date Title
ATE178316T1 (de) Verfahren zur herstellung von aminoalkylguanidinen
DE50305669D1 (de) Verfahren zur Herstellung von Polyisocyanaten der Diphenylmethanreihe durch Phosgenierung von nicht-neutralisiertem Polyamin der Diphenylmethanreihe
BR9405587A (pt) Processo para a produção de dímeros de ceteno
ATE387425T1 (de) Verfahren zur herstellung von bicalutamid
DE69917615D1 (de) Ein verfahren zur herstellung von (2s,2'r,3'r)-2-(2,3-dicarboxycyclopropyl)-glycin
DE50003759D1 (de) Verfahren zur herstellung von n-(4,5-bis-methansulfonyl-2-methyl-benzoyl)-guanidin, hydrochlorid
ATE273278T1 (de) Verfahren zur herstellung von 5-aminomethyl-2- chlorpyridinen
DE69926223D1 (de) Verfahren zur herstellung von zwischenprodukten
DE59803194D1 (de) Verfahren zur herstellung von 1,3-disubstituierten 2-nitroguanidinen
DE69707603D1 (de) Verfahren zur Herstellung von N2-Arylsulfonyl-L-Argininamiden
ATE188694T1 (de) Verfahren zur herstellung von benzopyranderivaten
DE59702822D1 (de) Verfahren zur herstellung von 2-fluor-1-cyclopropancarbonsäurederivaten durch reduktive enthalogenierung
ATE245138T1 (de) Verfahren zur herstellung von 2- trifluormethoxynalin
ATE165341T1 (de) Verfahren zur herstellung c-substituierter diethylentriamine
DE69620162T2 (de) Reduktives verfahren zur herstellung von ethylendiamindibernsteinsäure
DE69209094D1 (de) Verfahren zur herstellung von 2-amino-7-nitrobenzothiazolen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition